Visual Atlas · Context
The US legal landscape
Federal law, state frameworks, and local enforcement policies are separate layers. They do not create the same rights, and a change at one layer does not automatically change the others. This is educational information, not legal advice.
90-second quick read · deeper research available
Need the deeper research library?
This is the 90-second cliff-note read on imicrodosing.net. For cited research context, terminology, and broader education, use the full .org research library.
Textual legal update · July 22, 2026
The PNG evidence slides remain unchanged.
The surrounding HTML is the current legal layer: Oregon and Colorado regulate distinct supervised-service systems; New Mexico’s medical program is not yet open; local enforcement policy does not change state law; and every jurisdiction should be checked against official sources.
In brief
Federally, psilocybin and psilocyn remain Schedule I. Oregon licenses supervised psilocybin services and does not allow take-home products. Colorado protects specified adult personal-use activities without payment and licenses therapeutic services, while commercial sales remain prohibited. New Mexico enacted a medical program, but enrollment has not started and the Department of Health’s goal is to enroll the first patients by the end of December 2026.
Some local governments have adopted enforcement-priority or prosecutorial policies. Their wording and scope vary, and they do not repeal state possession, supply, retail, or cultivation law. A state service program, an implementation-stage medical law, a local policy, and full legalization are materially different legal conditions.
Visual walkthrough
Swipe or tap the arrows to move through 6 slides
Federal law, state frameworks, and local policy
Federal: Schedule I
Psilocybin and psilocyn remain listed in federal Schedule I. State and local reforms do not change that federal classification.
Oregon: supervised services, no take-home product
Adults 21 and older may access psilocybin services through licensed service centers after a preparation session. Products may be purchased and consumed only during the administration session and cannot leave the site.
Colorado: personal-use protections and licensed services
Colorado protects specified adult personal-use activities without payment and separately licenses therapeutic services. Commercial sales remain prohibited.
New Mexico: program in implementation
The Medical Psilocybin Act established a regulated medical program, but enrollment has not started. The Department of Health’s stated goal is to enroll the first patients by the end of December 2026.
Local policies: scope varies
Some cities use lowest-priority, non-enforcement, or prosecutorial policies. These do not create statewide possession, supply, retail, cultivation, or service-center rights.
Do not collapse different reforms
Reduced penalties, local enforcement deprioritization, protected personal use, supervised services, research, and medical access are separate legal categories. None should be described as ordinary retail access unless the law expressly authorizes it.
How strong the legal record is
Common questions
Answered directly
Q · 01
Is psilocybin legal across the United States?
No. Psilocybin and psilocyn remain Schedule I federally. Oregon and Colorado have distinct state frameworks, New Mexico’s medical program is not yet open, and local policies do not create nationwide or statewide legality.
Q · 02
Does local decriminalization create legal sales?
No. A local resolution may reduce enforcement priority or state a prosecutorial policy, but it does not authorize commercial sale, supply, cultivation, or a retail market under state law.
Q · 03
Which states currently regulate supervised services?
Oregon and Colorado have distinct licensed-service systems. Oregon requires on-site administration and prohibits take-home products. Colorado regulates therapeutic services and prohibits commercial sales. New Mexico’s enacted medical program remains in implementation.
Product-format context
For product-format context, see the iMicrodosing.com products and client support.
View products & support →Product-format context
Product descriptions, laboratory documentation, fulfillment policies, and client support remain on iMicrodosing.com. Deeper research remains on iMicrodosing.org.
Educational information only. Not medical advice. 21+ only.